Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP885695.RAqVO-4h1MSikbRCGVoUpzufOWI1lWh9PvaoHajaoORd4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP885695.RAqVO-4h1MSikbRCGVoUpzufOWI1lWh9PvaoHajaoORd4130_assertion type Assertion NP885695.RAqVO-4h1MSikbRCGVoUpzufOWI1lWh9PvaoHajaoORd4130_head.
- NP885695.RAqVO-4h1MSikbRCGVoUpzufOWI1lWh9PvaoHajaoORd4130_assertion description "[In conclusion, our study has revealed a new mode of PI3K alteration in primary endometrial tumors and warrants future studies to determine whether PIK3R1 mutations correlate with clinical outcome to targeted therapies directed against the PI3K pathway in EEC and NEEC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP885695.RAqVO-4h1MSikbRCGVoUpzufOWI1lWh9PvaoHajaoORd4130_provenance.
- NP885695.RAqVO-4h1MSikbRCGVoUpzufOWI1lWh9PvaoHajaoORd4130_assertion evidence source_evidence_literature NP885695.RAqVO-4h1MSikbRCGVoUpzufOWI1lWh9PvaoHajaoORd4130_provenance.
- NP885695.RAqVO-4h1MSikbRCGVoUpzufOWI1lWh9PvaoHajaoORd4130_assertion SIO_000772 21478295 NP885695.RAqVO-4h1MSikbRCGVoUpzufOWI1lWh9PvaoHajaoORd4130_provenance.
- NP885695.RAqVO-4h1MSikbRCGVoUpzufOWI1lWh9PvaoHajaoORd4130_assertion wasDerivedFrom befree-2016 NP885695.RAqVO-4h1MSikbRCGVoUpzufOWI1lWh9PvaoHajaoORd4130_provenance.
- NP885695.RAqVO-4h1MSikbRCGVoUpzufOWI1lWh9PvaoHajaoORd4130_assertion wasGeneratedBy ECO_0000203 NP885695.RAqVO-4h1MSikbRCGVoUpzufOWI1lWh9PvaoHajaoORd4130_provenance.